Literature DB >> 15930047

Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation.

Denise E Fedele1, Nicolette Gouder, Martin Güttinger, Laetitia Gabernet, Louis Scheurer, Thomas Rülicke, Florence Crestani, Detlev Boison.   

Abstract

Adenosine kinase (ADK) is considered to be the key regulator of the brain's endogenous anticonvulsant, adenosine. In adult brain, ADK is primarily expressed in a subpopulation of astrocytes and striking upregulation of ADK in these cells has been associated with astrogliosis after kainic acid-induced status epilepticus (KASE) in the kainic acid mouse model of temporal lobe epilepsy. To investigate the causal relationship between KASE-induced astrogliosis, upregulation of ADK and seizure activity, we have developed a novel mouse model [the Adktm1(-/-)-Tg(UbiAdk) mouse] lacking the endogenous astrocytic enzyme due to a targeted disruption of the endogenous gene, but containing an Adk transgene under the control of a human ubiquitin promoter. Mutant Adktm1(-/-)-Tg(UbiAdk) mice were characterized by increased brain ADK activity and constitutive overexpression of transgenic ADK throughout the brain, with particularly high levels in hippocampal pyramidal neurons. This ADK overexpression was associated with increased baseline levels of locomotion. Most importantly, two-thirds of the mutant mice analysed exhibited spontaneous seizure activity in the hippocampus and cortex. This was the direct consequence of transgene expression, since this seizure activity could be prevented by systemic application of the ADK inhibitor 5-iodotubercidin. Intrahippocampal injection of kainate in the mutant mice resulted in astrogliosis to the same extent as that observed in wild-type mice despite the absence of endogenous astrocytic ADK. Therefore, KASE-induced upregulation of endogenous ADK in wild-type mice is a consequence of astrogliosis. However, seizures in kainic acid-injected mutants displayed increased intra-ictal spike frequency compared with wild-type mice, indicating that, once epilepsy is established, increased levels of ADK aggravate seizure severity. We therefore conclude that therapeutic strategies that augment the adenosine system after astrogliosis-induced upregulation of ADK constitute a neurochemical rationale for the prevention of seizures in epilepsy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930047     DOI: 10.1093/brain/awh555

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  81 in total

1.  Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy.

Authors:  Eleonora Aronica; Emanuele Zurolo; Anand Iyer; Marjolein de Groot; Jasper Anink; Caterina Carbonell; Erwin A van Vliet; Johannes C Baayen; Detlev Boison; Jan A Gorter
Journal:  Epilepsia       Date:  2011-06-02       Impact factor: 5.864

2.  Adenosine kinase as a target for therapeutic antisense strategies in epilepsy.

Authors:  Panos Theofilas; Sukhmani Brar; Kerry-Ann Stewart; Hai-Ying Shen; Ursula S Sandau; David Poulsen; Detlev Boison
Journal:  Epilepsia       Date:  2011-01-28       Impact factor: 5.864

3.  Adenosine dysfunction and adenosine kinase in epileptogenesis.

Authors:  Detlev Boison
Journal:  Open Neurosci J       Date:  2010-01-01

4.  Targeting the brain: focal delivery of natural anticonvulsant molecules.

Authors:  Andrey Mazarati
Journal:  Epilepsy Curr       Date:  2005 Nov-Dec       Impact factor: 7.500

Review 5.  Glial adenosine kinase--a neuropathological marker of the epileptic brain.

Authors:  Eleonora Aronica; Ursula S Sandau; Anand Iyer; Detlev Boison
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

6.  Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control.

Authors:  Gaoying Ren; Tianfu Li; Jiang Quan Lan; Andrew Wilz; Roger P Simon; Detlev Boison
Journal:  Exp Neurol       Date:  2007-08-02       Impact factor: 5.330

7.  Opiate-induced changes in brain adenosine levels and narcotic drug responses.

Authors:  M Wu; P Sahbaie; M Zheng; R Lobato; D Boison; J D Clark; G Peltz
Journal:  Neuroscience       Date:  2012-10-22       Impact factor: 3.590

8.  Adenosine modulates transmission at the hippocampal mossy fibre synapse via direct inhibition of presynaptic calcium channels.

Authors:  A Gundlfinger; J Bischofberger; F W Johenning; M Torvinen; D Schmitz; J Breustedt
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

Review 9.  The ketogenic diet: metabolic influences on brain excitability and epilepsy.

Authors:  Andrew Lutas; Gary Yellen
Journal:  Trends Neurosci       Date:  2012-12-08       Impact factor: 13.837

Review 10.  Adenosine and Ketogenic Treatments.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  J Caffeine Adenosine Res       Date:  2020-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.